The global antibiotic susceptibility testing market, which totaled US$ 3 Billion in revenue in 2022, is anticipated to expand significantly, reaching a valuation of US$ 4.05 Billion by 2028, according to recent market research. The market is expected to grow at a compound annual growth rate (CAGR) of 5.2% during the forecast period.
Antibiotic susceptibility testing plays a crucial role in healthcare by guiding clinicians in the selection of appropriate antibiotic therapies. However, the market is subject to various macro and industrial dynamics, including drug and device regulations, product licensing, and product distribution.
Get The Sample Copy Of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-8574
One of the key developments driving the market forward is the advancement of novel MALDI-TOF mass spectrometry, which enables the rapid identification of disease pathogens or causative bacterial organisms, facilitating more targeted treatment approaches.
Despite these advancements, the market experienced a negative growth trend in the first half of 2022 compared to the projected period, with a decrease of 50 basis point share (BPS). This decline is attributed to the complex pre-analytical processes associated with antibiotic susceptibility testing, resulting in high procedural costs. Additionally, challenges such as the requirement for a significant quantity of viable organisms and a limited database spectrum for micro-organisms have contributed to the reduced BPS values.
However, the market is expected to witness positive growth momentum in the coming years with the anticipated introduction of microfluidics and microdroplets for antibiotic susceptibility testing. These technological innovations are projected to streamline testing processes and enhance the accuracy and efficiency of results, thereby driving market growth.
As the demand for effective antibiotic therapies continues to rise in the face of increasing antimicrobial resistance, the global antibiotic susceptibility testing market is poised for substantial expansion in the foreseeable future.
The two major factors driving growth in the antibiotic susceptibility testing market are:
- Advancements in Rapid AST Methods & Instruments: These innovations allow for quicker and more precise identification of which antibiotics will be most effective against a particular infection. This enables doctors to prescribe targeted therapies much sooner, leading to better patient outcomes and reduced risk of antibiotic resistance.
- Widespread usage of online channels for sales: The internet has revolutionized the way antibiotic susceptibility testing systems are sold. Vendors can now reach a much wider audience through online marketing and promotional strategies. Online platforms also provide a convenient way for customers to learn about different AST methods and compare prices. This increased accessibility and competition is helping to drive down costs and make AST more affordable for healthcare providers.
Customization with Our Report: https://www.futuremarketinsights.com/customization-available/rep-gb-8574
Competitive Landscape:
Major industry leaders have invested in enhancing their production facilities and actively pursue various research and development endeavors. Priorities for these key providers of antibiotic susceptibility testing systems include securing regulatory approvals, developing high-tech products, introducing new offerings, pursuing acquisitions, and fostering collaborative partnerships with other firms.
For instance,
Alifax recently introduced an innovative system for swift bacteria detection, offering antibiotic susceptibility and resistance testing within six hours. This system, employing the rapid phenotyping method, minimizes manual labor requirements, marking a significant advancement in the field.
Key Companies Profiled:
- BD
- Danaher
- Thermo Fisher Scientific
- Bio-Rad
- Creative Diagnostics
- Accelerate Diagnostics
- Alifax
- Roche Diagnostics Limited
- Merck Group
- Synbiosis
- MP Biomedicals
- QuantaMatrix Inc.
- Resistell AG
Key Segments of Antibiotic Susceptibility Testing Industry Survey:
Antibiotic Susceptibility Testing Market by Product:
- Instruments
- Automated Broth Microdilution Systems
- Manual Broth Microdilution Systems
- Semi-automated Broth Microdilution Systems
- Software & Services
- Image & Analysis Software
- Installation Services
- Kits & Reagents
Antibiotic Susceptibility Testing Market by Application:
- Sepsis
- Respiratory Infections
- Gastrointestinal Infections
- Meningitis & Encephalitis
- Endocarditis
- Others
Antibiotic Susceptibility Testing Market by End User:
- Diagnostic Laboratories
- Hospitals
- Research Laboratories
Antibiotic Susceptibility Testing Market by Region:
- North America Antibiotic Susceptibility Testing Market
- Latin America Antibiotic Susceptibility Testing Market
- Europe Antibiotic Susceptibility Testing Market
- East Asia Antibiotic Susceptibility Testing Market
- South Asia & Pacific Antibiotic Susceptibility Testing Market
- Middle East & Africa (MEA) Antibiotic Susceptibility Testing Market
Request Purchase Now: https://www.futuremarketinsights.com/checkout/8574
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
